Document Detail


Effect of high-dosage cholecalciferol and extended physiotherapy on complications after hip fracture: a randomized controlled trial.
MedLine Citation:
PMID:  20458090     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Care of elderly patients after hip fracture is not well established. METHODS: We enrolled 173 patients with acute hip fracture who were 65 years or older (79.2% women; mean age, 84 years; 77.4% living at home). Using a factorial design, we randomly allocated patients to extended physiotherapy (PT) (supervised 60 min/d during acute care plus an unsupervised home program) vs standard PT (supervised 30 min/d during acute care plus no home program; single-blinded), and to cholecalciferol therapy, 2000 vs 800 IU/d (double-blinded). Primary outcome was rate of falls; secondary outcome was rate of hospital readmissions during the 12-month follow-up. All analyses included 173 individuals and used multivariate Poisson regression analyses. RESULTS: At baseline, 50.9% of participants had 25-hydroxyvitamin D levels of less than 12 ng/mL and 97.7% of less than 30 ng/mL. We documented 212 falls and 74 hospital readmissions. Because this was a factorial design trial, all analyses tested the main effect of each treatment while controlling for the other in 173 participants. Extended vs standard PT reduced the rate of falls by 25% (95% confidence interval [CI], -44% to -1%). Cholecalciferol treatment, 2000 vs 800 IU/d, did not reduce falls (28%; 95% CI, -4% to 68%), but reduced the rate of hospital readmissions by 39% (95% CI, -62% to -1%). CONCLUSIONS: Extended PT was successful in reducing falls but not hospital readmissions, whereas cholecalciferol treatment, 2000 IU/d, was successful in reducing hospital readmission but not falls. Thus, the 2 strategies may be useful together because they address 2 different and important complications after hip fracture.
Authors:
Heike A Bischoff-Ferrari; Bess Dawson-Hughes; Andreas Platz; Endel J Orav; Hannes B Stähelin; Walter C Willett; Uenal Can; Andreas Egli; Nicolas J Mueller; Silvan Looser; Beat Bretscher; Elisabeth Minder; Athanasios Vergopoulos; Robert Theiler
Publication Detail:
Type:  Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Archives of internal medicine     Volume:  170     ISSN:  1538-3679     ISO Abbreviation:  Arch. Intern. Med.     Publication Date:  2010 May 
Date Detail:
Created Date:  2010-05-11     Completed Date:  2010-06-02     Revised Date:  2010-10-19    
Medline Journal Info:
Nlm Unique ID:  0372440     Medline TA:  Arch Intern Med     Country:  United States    
Other Details:
Languages:  eng     Pagination:  813-20     Citation Subset:  AIM; IM    
Affiliation:
Centre on Aging and Mobility, University of Zurich, University Hospital Zurich, Gloriastrasse 25, 8091 Zurich, Switzerland. Heike.Bischoff@usz.ch
Data Bank Information
Bank Name/Acc. No.:
ClinicalTrials.gov/NCT00133640
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Accidental Falls / prevention & control
Aged
Aged, 80 and over
Bone Density Conservation Agents / administration & dosage,  pharmacology,  therapeutic use*
Cholecalciferol / administration & dosage,  pharmacology,  therapeutic use*
Combined Modality Therapy
Dose-Response Relationship, Drug
Double-Blind Method
Drug Toxicity
Female
Hip Fractures / therapy*
Humans
Male
Multivariate Analysis
Patient Readmission
Physical Therapy Modalities*
Poisson Distribution
Recurrence
Regression Analysis
Switzerland
Chemical
Reg. No./Substance:
0/Bone Density Conservation Agents; 67-97-0/Cholecalciferol
Comments/Corrections
Comment In:
J Physiother. 2010;56(3):201   [PMID:  20795928 ]
Evid Based Med. 2010 Oct;15(5):144-5   [PMID:  20651101 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Processes of care associated with acute stroke outcomes.
Next Document:  Nut consumption and blood lipid levels: a pooled analysis of 25 intervention trials.